These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7027492)

  • 1. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C; Sinzinger H; Silberbauer K; Stummvoll HK
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemostaseopathies in chronic, azotemic renal insufficiency. Pathogenesis, diagnosis, treatment (author's transl)].
    Marx R; Murr H; Oey LS; Schramm W; Dobbelstein H
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1295-1300. PubMed ID: 819787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of platelet kinetics in chronic renal failure (conservative and regular dialysis treatment) (author's transl)].
    Lusvarghi E; Curci G; Sacchi S; Baraldi P; Baraldi A; Cappelli G; Landini S; Malmusi G; Orlandini G; Savazzi AM; Vandelli L; Quaglino D
    Haematologica; 1979 Dec; 64(6):747-58. PubMed ID: 121088
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin.
    Weksler BB
    Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of circulating prostacyclin.
    Haslam RJ; McClenaghan MD
    Nature; 1981 Jul; 292(5821):364-6. PubMed ID: 7019720
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal changes in uremia.
    Bonomini V; Orsoni G; Stefoni S; Vangelista A
    Clin Nephrol; 1979 Jun; 11(6):275-80. PubMed ID: 477043
    [No Abstract]   [Full Text] [Related]  

  • 13. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered platelet and vascular prostaglandin-generation in patients with renal failure and prolonged bleeding times.
    Remuzzi G; Marchesi D; Livio M; Cavenaghi AE; Mecca G; Donati MB; de Gaetano G
    Thromb Res; 1978 Dec; 13(6):1007-15. PubMed ID: 373157
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of the platelet aggregation in patients with chronic renal insufficiency under extracorporeal dialysis].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1975 Oct; 97(9):509-12. PubMed ID: 1223580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of serum ferritin assessment in the diagnosis of iron lack in uraemic patients (author's transl)].
    Quereda C; Escribano L; Vila T; Marcén R; García Laraña J; Estébanez C; Matesanz R; Navarro JL; Ortuño Mirete J
    Sangre (Barc); 1981; 26(4):447-55. PubMed ID: 7292227
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelets from uraemic patients react normally to prostacyclin.
    Pusineri F; Gotti E; Remuzzi G; Mecca G; Donati MB; de Gaetano G
    Int J Artif Organs; 1980 Mar; 3(2):125. PubMed ID: 6988339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 19. [A gas chromatographic-mass spectrometric analysis of organic acids in uremic ultrafiltrate (author's transl)].
    Maeda K; Niwa T; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):75-88. PubMed ID: 7289205
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin is a circulating hormone.
    Moncada S; Korbut R; Bunting S; Vane JR
    Nature; 1978 Jun; 273(5665):767-8. PubMed ID: 351418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.